They rank hundreds of personal care products and ingredients based on potential reproductive toxicity and other health risks
Microscopic analysis was employed to assess histopathological changes, with damage graded according to a previously established system (Sang et al., 2015)
Most available research is preclinical, and human clinical data remain limited
A thyroid gland complication increases the risk of developing melasma
Kailera acquired the rights to four metabolic drugs (outside of China) in May 2024 from Jiangsu Hengrui Pharmaceuticals
The NHS and NICE Recognition Second Natures approach to sustainable weight management has earned significant recognition from healthcare authorities: Used by the NHS since 2017 for type 2 diabetes management, prevention, and weight management programmes Recently approved by NICE as one of just four digital weight management services authorised to provide Wegovy alongside comprehensive support Over half of all UK NHS Health and Care boards have used Second Nature services This level of healthcare system trust reflects our commitment to evidence-based approaches that deliver meaningful, lasting results